INNOVATION IN DIGITAL HEALTH
Innovation is a process that starts with an
Datawizard is a catalyst for design thinking and innovation to resolve the most complex challenges in every project and team we are part of.
Datawizard helps organizations in exploring funding opportunities, partner matching, proposal development and management. Our dedicated scouting team is constantly searching for new opportunities to fund and build sustainable innovation projects.
Innovation Management Phases
Intelligent system for doctors to personalize drug prescriptions by analyzing patient and clinical data, drug interactions and genomic profile. Drug Pin is a project started by a group of scientists pioneering the field of personalised medicine.
ICT-based system for providing personalized nutrition. PROTEIN is a research initiative led by a consortium of European public and private sector organizations working to promote health and wellbeing. Grant 817732, H2020-SFS-2018-2020, 20 partners, 11 countries.
Up-scaling the global univocal identification of medicines – implementation of ISO IDMP standards in EU Member States drug databases, supporting safe cross-border ePrescription/ eDispensation and effective pharmacovigilance. Grant #875299. 48 partners, 19 countries. DATAWIZARD is the only Italian SME company involved in the project.
Supporting patients with chronic diseases, formal and informal caregivers and professionals for continuous care through emotional and vital parameters recognition crossed with Artificial Intelligence technologies. Grant 875325
Innovative Medicines Initiative project co-led by Pfizer and other pharma companies for improving patient health access, understanding and adherence to therapy, implementing ePI, EHR access and 2-way communication between patients and healthcare providers. Grant #945334. 41 partners, 15 countries.
IoT-based Emotion and Behaviour recognition Against elderly people Social Isolation (EBASI) – a multimodal sensor based recognition for social activities of daily living, integrated with the Diatomic system.
AI for Genomics and Personalised Medicine – aggregate health data from 66 healthcare teams in 15 countries to develop novel AI-based therapeutic approaches for rare hematological disorders.
Transforming health data sets (electronic health records, patient registries, hospital data, etc) into the OMOP common data model as a certified SME in the global OHDSI community. Datawizard has been selected by Società Italiana di Medicina Generale as key EHDEN Data Providers, to assist them in mapping more than 2 million patient health records to the OMOP common data model.